Oct 30, 2018 5:30 am EDT Achieve Life Sciences Announces Initiation of Phase 2b ORCA-1 Trial Evaluating Cytisinicline (cytisine) for Smoking Cessation
Sep 27, 2018 5:30 am EDT Achieve Announces Results of Clinical Study Demonstrating Similar Bioavailability for a New Cytisine Formulation in Fed and Fasted Subjects
Sep 26, 2018 5:30 am EDT Achieve to Present at the Ladenburg Thalmann 2018 Healthcare Conference on October 2, 2018
Sep 18, 2018 5:30 am EDT Achieve Announces Positive Cytisine Data Published in International Journal of Drug Policy
Sep 6, 2018 5:30 am EDT Achieve Life Sciences Announces Cytisine Data Presented at the Society for Research on Nicotine and Tobacco Europe (SRNT-E) Annual Conference
Sep 5, 2018 5:30 am EDT Achieve to Present at the H.C. Wainwright 20th Annual Global Investment Conference on September 6, 2018
Aug 8, 2018 4:05 pm EDT Achieve Reports Financial Results for Second Quarter 2018 and Provides Cytisine Clinical Development Update
Aug 2, 2018 5:30 am EDT Achieve Life Sciences to Release Second Quarter 2018 Financial Results and Host Conference Call and Webcast on August 8, 2018
Jul 11, 2018 5:30 am EDT Achieve Life Sciences Announces Advancement of Cytisine Development Program Following Meeting with the FDA
